Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront

被引：0
|
作者：
Jimenez, J. Torres [1 ,2 ]
Gorria, T. [2 ]
Auclin, E. [3 ]
Castro, N. [4 ]
Albarran-Artahona, V. [2 ]
Ruffinelli, J. C. [5 ]
Pinato, D. [6 ]
Routy, B. [7 ]
Nana, F. Aboubakar
Reyes, R. [2 ]
Vinolas, N. [2 ,9 ]
Blanc-Durand, F. [8 ,10 ]
Lopes, G. [11 ]
Nadal, E. [12 ]
Arasanz, H. [4 ,13 ]
Pascal, M. [2 ,9 ]
Teixido, C. [2 ]
Besse, B. [10 ]
Reguart, N. [2 ,9 ]
Mezquita, L. [2 ,9 ]
Jimenez, J. Torres [1 ,2 ]
机构：
[1] Hosp Univ Ramon & Cajal, Madrid, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
[3] Univ Paris, Hop European George Pompidou, AP HP, Paris, France
[4] Hosp Univ Navarra, Pamplona, Spain
[5] Catalan Inst Oncol, Barcelona, Spain
[6] Hammersmith Hosp, Imperial Coll London, London, England
[7] Ctr Hosp Univ Montreal CHUM, Montreal, PQ, Canada
[8] Catholic Univ Louvain, Brussels, Belgium
[9] August Pi & Sunyer Biomed Res Inst IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumor, Barcelona, Spain
[10] Gustave Roussy, Villejuif, France
[11] Univ Miami, Miami, FL USA
[12] Catalan Inst Oncol, Lhospitalet De Llobregat, Spain
[13] IdiSNA, Oncoimmunol Grp, Navarrabiomed, Pamplona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Gender; Immunotherapy alone; Immunotherapy combination with chemotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP08.01-09
引用
收藏
页码：S385 / S386
页数：2
相关论文
共 50 条
  • [41] Prospect of immunotherapy alone in patients with advanced NSCLC with high btmb: a review and a meta-analysis
    Feiyu Zhao
    Xiaochen Qiu
    Qinna Yang
    Shuyue Gao
    Fan Yang
    Niansong Qian
    Holistic Integrative Oncology, 2 (1):
  • [42] Use of Biosimulation to Predict Chemotherapy Benefit in Patients with Metastatic NSCLC Being Treated with Immunotherapy
    Klein, M.
    Watson, D.
    Kapoor, S.
    Nair, P. R.
    Rajagopalan, S.
    Glaser, M.
    Sharif, N.
    Stonebarger, M.
    Westanmo, A.
    Lala, D. A.
    Kumar, A.
    Chauhan, J.
    Ullal, Y. S.
    Kulkarni, S.
    Ghosh, A.
    Narvekar, Y.
    Patil, M.
    Castro, M.
    Macpherson, M.
    Wingrove, J.
    Patil, T.
    Ganti, A.
    Aggarwal, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S89 - S89
  • [43] Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
    Ezewuiro, Obiageli
    Grushko, Tatyana A.
    Kocherginsky, Masha
    Habis, Mohammed
    Hurteau, Jean A.
    Mills, Kathryn A.
    Hunn, Jessica
    Olopade, Olufunmilayo I.
    Fleming, Gini F.
    Romero, Iris L.
    PLOS ONE, 2016, 11 (01):
  • [44] Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab
    Seban, Romain-David
    Assie, Jean-Baptiste
    Giroux-Leprieur, Etienne
    Massiani, Marie-Ange
    Soussan, Michael
    Bonardel, Gerald
    Chouaid, Christos
    Playe, Margot
    Goldfarb, Lucas
    Duchemann, Boris
    Mezquita, Laura
    Girard, Nicolas
    Champion, Laurence
    CANCERS, 2020, 12 (08) : 1 - 14
  • [45] DELTA-RADIOMICS SIGNATURE FOR PREDICTION OF SURVIVAL IN ADVANCED NSCLC PATIENTS TREATED WITH IMMUNOTHERAPY
    Farina, B.
    Ramos Guerra, A. D.
    Palacios Miras, C.
    Gallardo Madueno, G.
    Munoz-Barrutia, Arrate
    Peces-Barba, G. R.
    Seijo Maceiras, L.
    Corral, J.
    Gil-Bazo, I
    Domine Gomez, M.
    Ledesma-Carbayo, M. J.
    2021 IEEE 18TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), 2021, : 886 - 890
  • [46] RECIST and iRECIST Comparison in a Cohort of Patients with Advanced NSCLC Treated with Immunotherapy: Preliminary Study
    Garcia Martinez, F.
    Fernandez-Velilla Pena, M.
    Cruz Castellanos, P.
    De Castro Carpeno, J.
    Pertejo, A.
    Torres Sanchez, I.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S980 - S980
  • [47] Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy
    Ren, Shengxiang
    Zhou, Songwen
    Wu, Fengyin
    Zhang, Ling
    Li, Xuefei
    Zhang, Jie
    Xu, Jianfang
    Lv, Meijun
    Zhang, Jie
    Zhou, Caicun
    LUNG CANCER, 2012, 75 (01) : 102 - 109
  • [48] Association of Systemic Inflammatory and Immune Indices With Survival in Canine Patients With Oral Melanoma, Treated With Experimental Immunotherapy Alone or Experimental Immunotherapy Plus Metronomic Chemotherapy
    Garcia, Jessica Soares
    Nowosh, Victor
    Lopez, Rossana Veronica Mendoza
    Massoco, Cristina de Oliveira
    FRONTIERS IN VETERINARY SCIENCE, 2022, 9
  • [49] Gut resistome of NSCLC patients treated with immunotherapy
    Iwan, Ewelina
    Grenda, Anna
    Bomba, Arkadiusz
    Bielinska, Katarzyna
    Wasyl, Dariusz
    Kieszko, Robert
    Rolska-Kopinska, Anna
    Chmielewska, Izabela
    Krawczyk, Pawel
    Rybczynska-Tkaczyk, Kamila
    Olejnik, Malgorzata
    Milanowski, Janusz
    FRONTIERS IN GENETICS, 2024, 15
  • [50] Phase III clinical trials of atezolizumab in combination with chemotherapy in chemotherapy-naive patients with advanced NSCLC
    Mok, T. S. K.
    Cappuzzo, F.
    Jotte, R. M.
    Reck, M.
    Papadimitrakopoulou, V.
    Sandler, A.
    Waterkamp, D.
    Verret, W.
    Shen, Y.
    Socinski, M. A.
    ANNALS OF ONCOLOGY, 2015, 26 : 106 - 106
12345